Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
35 participants
INTERVENTIONAL
2022-02-11
2023-07-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Acute Timed Exercise and 24h Metabolism
NCT05073068
Exercise to Restore 24h Rhythms in Metabolism
NCT04565418
Circadian Rhythm and Metabolic Effects of Exercise
NCT05115682
High-Intensity Interval or Concurrent Exercise on Oxidative Stress and Inflammation in Obese Women
NCT07302191
Females, Aging, Metabolism, and Exercise
NCT01712230
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Specific aims of this project are a) to describe possible differences dependent on sex in the diurnal variation of the effect of exercise on glycemic metabolism and fat oxidation, and b) to characterize the molecular mechanisms implicated.
18 men and 17 women with normal weight will be randomized into two conditions (morning and evening) with at least 3 days of separation in between. Each evaluation will conform the following tests:
1. Basal metabolic rate assessment through indirect calorimetry during 30 minutes.
2. Fuel oxidation and energy expenditure assesment during a 60 minutes bout of aerobic steady-state exercise (cycling), through indirect calorimetry.
3. Fuel oxidation and energy expenditure assesment after exercise during 30 minutes, through indirect calorimetry.
4. Blood samples assesment before, inmediately after, and 90 minutes after exercise.
5. Quadriceps biopsies before, and inmediately after exercise. \*This will be done only in a sub-cohort.
6. Visual analog scales to assess appetite before, inmediately after, and 90 minutes after exercise.
7. Continous glucose monitoring from the previous 24 hrs to first session day, until 48 hrs after the last exercise session.
Previous to this, participants' body composition and fitness level will be assesed via densitometry and a maximal exercise test, respectively.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Morning
60 minutes cycling on cycle ergometer in the morning (11:30). Steady-state test at an intensity of 65% of participant's heart rate reserve.
Exercise
Aerobic exercise
Evening
60 minutes cycling on cycle ergometer in the evening (18:30). Steady-state test at an intensity of 65% of participant's heart rate reserve.
Exercise
Aerobic exercise
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Exercise
Aerobic exercise
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Physical activty \< 5 days/week.
* To be able to understand instrucctions, objectives and study protocol.
Exclusion Criteria
* Rheumatoid arthritis, Parkinson's disease, active cancer treatment in the past year, type 1 diabetes mellitus, or another medical condition for which fasting is contraindicated.
* Any condition that, in the judgment of the investigator, impairs the ability to participate in the study or poses a personal risk to the participant.
* Use of medications that may affect the results of the study.
* Unstable body weight for 3 months before the start of the study (\> 4 kg weight loss or gain)
* Pregnancy and breastfeeding.
* Active tobacco abuse or illicit drug use or a history of alcohol abuse treatment.
* On a special diet or prescribed for other reasons (eg celiac disease).
18 Years
50 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universidad de Granada
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jonatan Ruiz Ruiz
Director
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jonatan Ruiz Ruiz, Dr.
Role: PRINCIPAL_INVESTIGATOR
Granada University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Granada - Instituto Mixto Universitario Deporte y Salud
Granada, , Spain
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DIVA project
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.